Concepedia

Karl Staser

KS

21

Publications

1.6K

Citations

19

H-Index

2011

Active since

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Washington University in St. Louis

Indiana University School of Medicine

Massachusetts General Hospital

Harvard University

Karl Staser is an author at Indiana University – Purdue University Indianapolis specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

2011–2023

21

Publications

21

An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Matthew Cooper, Jaebok Choi, Karl Staser et al. · Leukemia · 2018 · 381 citations · Full text

, , +5

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial

Kent A. Robertson, Grzegorz Nalepa, Feng‐Chun Yang et al. · The Lancet Oncology · 2012 · 226 citations · Full text

, , +5

Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity

Yongzheng He, Karl Staser, Steven D. Rhodes et al. · PLoS ONE · 2011 · 125 citations · Full text

A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation

Jeffrey R. Gehlhausen, Su-Jung Park, Ann E. Hickox et al. · Human Molecular Genetics · 2014 · 107 citations · Full text

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia et al. · Blood Advances · 2020 · 94 citations · Full text

Rows per page

1–5 of 21